Biomea Fusion Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Biomea Fusion, Inc. (BMEA) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-138.43-117.26-81.83-41.57-5.32
Depreciation & Amortization1.751.521.270.250.01
Stock Based Compensation19.0914.1310.346.230.32
Change in Working Capital-5.152.338.23-1.570.41
Change in Accounts Payable6.092.562.960.640.42
Change in Other Working Capital-11.242.694.710.70-0.01
Other Operating Activities2.842.699.920.700.12
Net Cash from Operating Activities-119.89-96.59-62.42-35.44-4.46
Investing Activities
Capital Expenditures-0.36-3.371.03-3.17-0.05
Purchases of Investments0.001.1528.37-38.490.00
Sales/Maturities of Investments0.001.1528.378.310.00
Net Cash from Investing Activities-0.36-2.2227.34-33.36-0.05
Financing Activities
Debt Repayment0.000.000.00-0.040.00
Common Stock Issued1.67161.801.24152.7510.19
Net Cash from Financing Activities1.67163.801.24153.1965.97
Summary
Net Change in Cash-118.5964.99-33.8484.3961.46
Cash at Beginning of Period177.24112.25146.0961.700.00
Cash at End of Period58.65177.24112.25146.090.00
Free Cash Flow-120.26-99.96-63.45-38.61-4.51